| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autism Spectrum Disorder | 14 | 2023 | 23 | 6.470 |
Why?
|
| Autistic Disorder | 9 | 2024 | 44 | 4.840 |
Why?
|
| Pediatrics | 15 | 2025 | 39 | 4.080 |
Why?
|
| Humans | 96 | 2026 | 6794 | 3.480 |
Why?
|
| Transition to Adult Care | 9 | 2022 | 23 | 3.460 |
Why?
|
| Child | 34 | 2025 | 524 | 2.490 |
Why?
|
| Child Health | 5 | 2022 | 8 | 2.320 |
Why?
|
| Minority Groups | 5 | 2022 | 63 | 2.300 |
Why?
|
| Primary Health Care | 9 | 2026 | 78 | 1.950 |
Why?
|
| Female | 40 | 2023 | 4060 | 1.850 |
Why?
|
| Adolescent | 29 | 2025 | 869 | 1.830 |
Why?
|
| Students | 6 | 2022 | 40 | 1.820 |
Why?
|
| Physician's Role | 7 | 2018 | 15 | 1.780 |
Why?
|
| Child Health Services | 10 | 2020 | 17 | 1.780 |
Why?
|
| Health Personnel | 8 | 2023 | 49 | 1.750 |
Why?
|
| Male | 34 | 2023 | 3671 | 1.680 |
Why?
|
| Child Development | 6 | 2013 | 21 | 1.550 |
Why?
|
| United States | 26 | 2023 | 1019 | 1.540 |
Why?
|
| Young Adult | 19 | 2024 | 567 | 1.530 |
Why?
|
| Surveys and Questionnaires | 10 | 2022 | 280 | 1.520 |
Why?
|
| Child, Preschool | 21 | 2021 | 258 | 1.520 |
Why?
|
| Adult | 22 | 2024 | 2113 | 1.470 |
Why?
|
| Parents | 6 | 2018 | 42 | 1.450 |
Why?
|
| Career Choice | 5 | 2022 | 17 | 1.430 |
Why?
|
| Internship and Residency | 4 | 2022 | 62 | 1.390 |
Why?
|
| Patient Transfer | 3 | 2022 | 11 | 1.280 |
Why?
|
| Mothers | 4 | 2015 | 17 | 1.270 |
Why?
|
| Developmental Disabilities | 3 | 2018 | 6 | 1.190 |
Why?
|
| Poverty | 7 | 2018 | 64 | 1.090 |
Why?
|
| Mexican Americans | 4 | 2016 | 14 | 1.060 |
Why?
|
| Social Behavior | 3 | 2020 | 14 | 1.060 |
Why?
|
| Mentors | 5 | 2022 | 19 | 1.020 |
Why?
|
| Health Promotion | 7 | 2018 | 89 | 0.950 |
Why?
|
| Psychiatric Nursing | 1 | 2025 | 2 | 0.930 |
Why?
|
| Nurse Practitioners | 1 | 2025 | 4 | 0.930 |
Why?
|
| Curriculum | 5 | 2022 | 53 | 0.930 |
Why?
|
| Health Occupations | 2 | 2015 | 3 | 0.920 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2024 | 10 | 0.890 |
Why?
|
| Mental Health | 4 | 2023 | 70 | 0.890 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2015 | 8 | 0.850 |
Why?
|
| Disabled Persons | 2 | 2022 | 4 | 0.830 |
Why?
|
| Universities | 5 | 2022 | 21 | 0.820 |
Why?
|
| Mental Disorders | 4 | 2023 | 60 | 0.760 |
Why?
|
| Program Development | 4 | 2022 | 34 | 0.750 |
Why?
|
| Family Characteristics | 2 | 2021 | 13 | 0.730 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 172 | 0.730 |
Why?
|
| Tobacco Products | 1 | 2022 | 14 | 0.730 |
Why?
|
| Health Status | 3 | 2012 | 83 | 0.720 |
Why?
|
| Vaping | 1 | 2022 | 26 | 0.710 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 11 | 0.710 |
Why?
|
| Cognition | 2 | 2013 | 30 | 0.700 |
Why?
|
| Pediatricians | 2 | 2018 | 3 | 0.700 |
Why?
|
| Stakeholder Participation | 2 | 2018 | 9 | 0.700 |
Why?
|
| Infant | 11 | 2017 | 187 | 0.690 |
Why?
|
| Body Mass Index | 4 | 2017 | 145 | 0.690 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2022 | 58 | 0.680 |
Why?
|
| Parenting | 3 | 2015 | 18 | 0.680 |
Why?
|
| Social Work | 2 | 2020 | 5 | 0.670 |
Why?
|
| Health Status Disparities | 4 | 2016 | 83 | 0.660 |
Why?
|
| Health Services Accessibility | 7 | 2022 | 145 | 0.640 |
Why?
|
| Personnel Selection | 1 | 2020 | 3 | 0.640 |
Why?
|
| Interviews as Topic | 2 | 2018 | 77 | 0.630 |
Why?
|
| Health Policy | 2 | 2018 | 26 | 0.610 |
Why?
|
| Biomedical Research | 2 | 2024 | 34 | 0.600 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 14 | 0.590 |
Why?
|
| Child Welfare | 3 | 2013 | 8 | 0.590 |
Why?
|
| Parent-Child Relations | 2 | 2018 | 13 | 0.580 |
Why?
|
| Depression | 2 | 2022 | 128 | 0.570 |
Why?
|
| Health Services Research | 2 | 2018 | 27 | 0.570 |
Why?
|
| Health Services Needs and Demand | 4 | 2015 | 32 | 0.570 |
Why?
|
| Algorithms | 1 | 2018 | 83 | 0.560 |
Why?
|
| Public Health | 1 | 2018 | 40 | 0.560 |
Why?
|
| Goals | 1 | 2018 | 8 | 0.560 |
Why?
|
| Health Resources | 1 | 2018 | 12 | 0.560 |
Why?
|
| Intersectoral Collaboration | 1 | 2018 | 4 | 0.550 |
Why?
|
| Mentoring | 3 | 2022 | 12 | 0.550 |
Why?
|
| Inpatients | 1 | 2018 | 22 | 0.540 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 7 | 0.500 |
Why?
|
| Physicians | 2 | 2017 | 49 | 0.500 |
Why?
|
| Research Personnel | 1 | 2016 | 9 | 0.500 |
Why?
|
| Maternal-Child Health Centers | 2 | 2022 | 2 | 0.500 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2014 | 153 | 0.490 |
Why?
|
| Father-Child Relations | 1 | 2016 | 3 | 0.480 |
Why?
|
| Feeding Behavior | 1 | 2016 | 38 | 0.470 |
Why?
|
| Maternal Health | 1 | 2015 | 4 | 0.470 |
Why?
|
| Body Weight | 2 | 2016 | 90 | 0.460 |
Why?
|
| Pediatric Obesity | 1 | 2015 | 7 | 0.450 |
Why?
|
| Emergency Medical Services | 3 | 2023 | 19 | 0.450 |
Why?
|
| Education, Public Health Professional | 1 | 2015 | 1 | 0.450 |
Why?
|
| Maternal Welfare | 1 | 2015 | 2 | 0.450 |
Why?
|
| Hearing Loss | 2 | 2013 | 13 | 0.440 |
Why?
|
| Communication | 2 | 2015 | 31 | 0.430 |
Why?
|
| Los Angeles | 6 | 2022 | 321 | 0.430 |
Why?
|
| Interinstitutional Relations | 1 | 2014 | 1 | 0.420 |
Why?
|
| Adolescent Development | 1 | 2014 | 15 | 0.420 |
Why?
|
| Plagiocephaly, Nonsynostotic | 1 | 2014 | 1 | 0.420 |
Why?
|
| Torticollis | 1 | 2014 | 2 | 0.420 |
Why?
|
| Schools | 1 | 2014 | 25 | 0.420 |
Why?
|
| Mass Screening | 3 | 2013 | 116 | 0.410 |
Why?
|
| Chronic Disease | 5 | 2026 | 167 | 0.400 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2013 | 5 | 0.400 |
Why?
|
| Health Education | 1 | 2013 | 55 | 0.400 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2010 | 49 | 0.390 |
Why?
|
| Middle Aged | 8 | 2021 | 2108 | 0.390 |
Why?
|
| Public Health Administration | 1 | 2012 | 4 | 0.380 |
Why?
|
| Public Policy | 2 | 2016 | 8 | 0.380 |
Why?
|
| Infant Food | 1 | 2011 | 1 | 0.360 |
Why?
|
| Socioeconomic Factors | 8 | 2017 | 197 | 0.360 |
Why?
|
| Weaning | 1 | 2011 | 6 | 0.360 |
Why?
|
| Emergencies | 4 | 2023 | 11 | 0.360 |
Why?
|
| Professional Competence | 1 | 2011 | 3 | 0.350 |
Why?
|
| Patient Advocacy | 1 | 2011 | 8 | 0.350 |
Why?
|
| Politics | 1 | 2011 | 7 | 0.350 |
Why?
|
| Education, Medical | 1 | 2011 | 20 | 0.350 |
Why?
|
| Anxiety | 2 | 2022 | 35 | 0.350 |
Why?
|
| Mental Health Services | 3 | 2025 | 15 | 0.350 |
Why?
|
| Self Report | 2 | 2024 | 35 | 0.340 |
Why?
|
| Obesity | 5 | 2026 | 226 | 0.340 |
Why?
|
| Pandemics | 2 | 2022 | 87 | 0.340 |
Why?
|
| Program Evaluation | 5 | 2022 | 46 | 0.340 |
Why?
|
| Guideline Adherence | 1 | 2010 | 18 | 0.330 |
Why?
|
| Papillomavirus Vaccines | 1 | 2010 | 8 | 0.320 |
Why?
|
| Infant Welfare | 1 | 2010 | 1 | 0.320 |
Why?
|
| Clinical Clerkship | 2 | 2001 | 19 | 0.320 |
Why?
|
| Vaccination | 1 | 2010 | 49 | 0.310 |
Why?
|
| Retrospective Studies | 4 | 2024 | 681 | 0.300 |
Why?
|
| Risk Factors | 6 | 2016 | 767 | 0.300 |
Why?
|
| Emigration and Immigration | 1 | 2009 | 13 | 0.300 |
Why?
|
| Child Behavior Disorders | 2 | 2023 | 5 | 0.280 |
Why?
|
| Prospective Studies | 3 | 2021 | 331 | 0.280 |
Why?
|
| Delphi Technique | 2 | 2018 | 16 | 0.280 |
Why?
|
| Internal Medicine | 2 | 2017 | 9 | 0.260 |
Why?
|
| Age Factors | 5 | 2013 | 193 | 0.260 |
Why?
|
| Preventive Medicine | 1 | 2006 | 5 | 0.250 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 140 | 0.250 |
Why?
|
| Anemia, Sickle Cell | 1 | 2026 | 7 | 0.240 |
Why?
|
| Family | 2 | 2018 | 27 | 0.240 |
Why?
|
| Health Care Surveys | 4 | 2018 | 28 | 0.240 |
Why?
|
| Interprofessional Relations | 1 | 2025 | 13 | 0.230 |
Why?
|
| Health Surveys | 2 | 2022 | 75 | 0.230 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2025 | 15 | 0.230 |
Why?
|
| California | 3 | 2022 | 230 | 0.220 |
Why?
|
| Residence Characteristics | 2 | 2015 | 36 | 0.220 |
Why?
|
| Breast Feeding | 2 | 2017 | 14 | 0.220 |
Why?
|
| Reading | 1 | 2004 | 3 | 0.210 |
Why?
|
| Learning | 1 | 2024 | 11 | 0.210 |
Why?
|
| Aged | 2 | 2024 | 1539 | 0.210 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 9 | 0.200 |
Why?
|
| Logistic Models | 5 | 2014 | 165 | 0.200 |
Why?
|
| Leadership | 3 | 2022 | 22 | 0.200 |
Why?
|
| Infant, Newborn | 4 | 2017 | 199 | 0.190 |
Why?
|
| Urokinase-Type Plasminogen Activator | 3 | 2010 | 5 | 0.190 |
Why?
|
| Longevity | 1 | 2022 | 7 | 0.180 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 102 | 0.180 |
Why?
|
| Medicaid | 2 | 2020 | 19 | 0.180 |
Why?
|
| Case-Control Studies | 1 | 2022 | 108 | 0.180 |
Why?
|
| Cross-Sectional Studies | 5 | 2016 | 506 | 0.180 |
Why?
|
| Urban Population | 2 | 2014 | 85 | 0.180 |
Why?
|
| Masks | 1 | 2021 | 2 | 0.180 |
Why?
|
| Hand Hygiene | 1 | 2021 | 3 | 0.180 |
Why?
|
| Capacity Building | 3 | 2022 | 5 | 0.180 |
Why?
|
| Presenteeism | 1 | 2021 | 1 | 0.180 |
Why?
|
| Social Isolation | 1 | 2021 | 10 | 0.180 |
Why?
|
| Stress, Psychological | 1 | 2022 | 60 | 0.180 |
Why?
|
| Prevalence | 1 | 2022 | 259 | 0.170 |
Why?
|
| Psychomotor Disorders | 1 | 2001 | 1 | 0.170 |
Why?
|
| Sleep Deprivation | 1 | 2001 | 2 | 0.170 |
Why?
|
| Cognition Disorders | 1 | 2001 | 19 | 0.170 |
Why?
|
| Achievement | 1 | 2021 | 2 | 0.170 |
Why?
|
| Family Practice | 1 | 2001 | 21 | 0.170 |
Why?
|
| Weight Loss | 1 | 2021 | 35 | 0.170 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 71 | 0.160 |
Why?
|
| Telemedicine | 1 | 2021 | 43 | 0.160 |
Why?
|
| Quality of Life | 1 | 2022 | 184 | 0.160 |
Why?
|
| Social Environment | 2 | 2018 | 17 | 0.160 |
Why?
|
| Overweight | 2 | 2021 | 30 | 0.160 |
Why?
|
| Employment | 1 | 2020 | 17 | 0.160 |
Why?
|
| Career Mobility | 1 | 2019 | 2 | 0.160 |
Why?
|
| Exercise | 2 | 2021 | 55 | 0.160 |
Why?
|
| Educational Measurement | 2 | 2015 | 18 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 1999 | 21 | 0.150 |
Why?
|
| Emergency Service, Hospital | 3 | 2023 | 64 | 0.150 |
Why?
|
| Clinical Competence | 1 | 1999 | 51 | 0.140 |
Why?
|
| Early Medical Intervention | 1 | 2018 | 4 | 0.140 |
Why?
|
| Educational Status | 3 | 2009 | 61 | 0.140 |
Why?
|
| Congresses as Topic | 1 | 2018 | 20 | 0.140 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 11 | 0.140 |
Why?
|
| Qualitative Research | 1 | 2018 | 82 | 0.130 |
Why?
|
| House Calls | 1 | 2017 | 2 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2018 | 30 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 84 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2017 | 285 | 0.130 |
Why?
|
| Preconception Care | 1 | 2017 | 2 | 0.130 |
Why?
|
| Reproductive Health | 1 | 2017 | 9 | 0.130 |
Why?
|
| Genome, Fungal | 1 | 2017 | 1 | 0.130 |
Why?
|
| Mortierella | 1 | 2017 | 1 | 0.130 |
Why?
|
| Burkholderiaceae | 1 | 2017 | 1 | 0.130 |
Why?
|
| Symbiosis | 1 | 2017 | 2 | 0.130 |
Why?
|
| Genome, Bacterial | 1 | 2017 | 4 | 0.130 |
Why?
|
| Carbohydrate Metabolism | 1 | 2017 | 10 | 0.130 |
Why?
|
| Alaska Natives | 1 | 2017 | 1 | 0.130 |
Why?
|
| Indians, North American | 1 | 2017 | 5 | 0.130 |
Why?
|
| Health Behavior | 2 | 2014 | 65 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 33 | 0.130 |
Why?
|
| Insurance, Health | 3 | 2012 | 26 | 0.130 |
Why?
|
| Hospitalization | 1 | 2018 | 128 | 0.130 |
Why?
|
| Disabled Children | 2 | 2007 | 2 | 0.130 |
Why?
|
| Adaptation, Psychological | 2 | 2014 | 35 | 0.120 |
Why?
|
| Fast Foods | 1 | 2016 | 1 | 0.120 |
Why?
|
| DNA-Binding Proteins | 4 | 2001 | 38 | 0.120 |
Why?
|
| Interpersonal Relations | 2 | 2014 | 20 | 0.120 |
Why?
|
| Transcription Factors | 4 | 2001 | 53 | 0.120 |
Why?
|
| Community Participation | 1 | 2015 | 13 | 0.120 |
Why?
|
| Food Supply | 1 | 2015 | 11 | 0.120 |
Why?
|
| Epidemiology | 1 | 2015 | 1 | 0.110 |
Why?
|
| Education, Professional | 1 | 2015 | 1 | 0.110 |
Why?
|
| Sampling Studies | 1 | 2015 | 13 | 0.110 |
Why?
|
| Asthma | 2 | 2012 | 31 | 0.110 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 51 | 0.110 |
Why?
|
| Birth Weight | 2 | 2017 | 33 | 0.110 |
Why?
|
| Early Diagnosis | 2 | 2013 | 26 | 0.110 |
Why?
|
| Food Labeling | 1 | 2014 | 1 | 0.110 |
Why?
|
| Comprehension | 1 | 2014 | 7 | 0.110 |
Why?
|
| Receptors, Cell Surface | 2 | 2006 | 29 | 0.110 |
Why?
|
| Botulinum Toxins | 1 | 2014 | 1 | 0.110 |
Why?
|
| Orthotic Devices | 1 | 2014 | 1 | 0.110 |
Why?
|
| Physical Therapy Modalities | 1 | 2014 | 1 | 0.110 |
Why?
|
| Posture | 1 | 2014 | 4 | 0.110 |
Why?
|
| Skull | 1 | 2014 | 10 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 111 | 0.100 |
Why?
|
| Least-Squares Analysis | 1 | 2013 | 2 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 79 | 0.100 |
Why?
|
| Eligibility Determination | 1 | 2013 | 4 | 0.100 |
Why?
|
| Disability Evaluation | 1 | 2013 | 7 | 0.100 |
Why?
|
| Acculturation | 2 | 2010 | 4 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 75 | 0.100 |
Why?
|
| Acoustic Impedance Tests | 1 | 2013 | 1 | 0.100 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2013 | 1 | 0.100 |
Why?
|
| Audiometry | 1 | 2013 | 6 | 0.100 |
Why?
|
| Oral Health | 1 | 2012 | 1 | 0.100 |
Why?
|
| Environmental Health | 1 | 2012 | 3 | 0.100 |
Why?
|
| Environmental Exposure | 1 | 2012 | 12 | 0.100 |
Why?
|
| Violence | 1 | 2012 | 52 | 0.090 |
Why?
|
| Hypercholesterolemia | 1 | 2012 | 13 | 0.090 |
Why?
|
| Cholesterol | 1 | 2012 | 37 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2012 | 18 | 0.090 |
Why?
|
| Life Style | 1 | 2012 | 51 | 0.090 |
Why?
|
| Focus Groups | 1 | 2011 | 46 | 0.090 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 35 | 0.090 |
Why?
|
| Nuclear Proteins | 4 | 2001 | 17 | 0.090 |
Why?
|
| Adolescent Health Services | 1 | 2010 | 6 | 0.080 |
Why?
|
| Cooperative Behavior | 2 | 2024 | 28 | 0.080 |
Why?
|
| Parental Consent | 1 | 2010 | 1 | 0.080 |
Why?
|
| Single-Chain Antibodies | 1 | 2010 | 2 | 0.080 |
Why?
|
| Prodrugs | 1 | 2010 | 2 | 0.080 |
Why?
|
| Hypertension | 1 | 2012 | 147 | 0.080 |
Why?
|
| Enzyme Precursors | 1 | 2010 | 6 | 0.080 |
Why?
|
| Sick Role | 1 | 2010 | 3 | 0.080 |
Why?
|
| Internal-External Control | 1 | 2010 | 5 | 0.080 |
Why?
|
| Family Conflict | 1 | 2010 | 3 | 0.080 |
Why?
|
| Fibrinolytic Agents | 1 | 2010 | 5 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 10 | 0.080 |
Why?
|
| Child of Impaired Parents | 1 | 2010 | 4 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 12 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2010 | 14 | 0.080 |
Why?
|
| Thrombosis | 1 | 2010 | 13 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2010 | 27 | 0.080 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 42 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 83 | 0.080 |
Why?
|
| Developed Countries | 1 | 2009 | 7 | 0.080 |
Why?
|
| Social Support | 1 | 2010 | 67 | 0.080 |
Why?
|
| Maternal Behavior | 1 | 2009 | 3 | 0.080 |
Why?
|
| Nurses | 1 | 2009 | 8 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 72 | 0.080 |
Why?
|
| Health Services | 1 | 2009 | 12 | 0.080 |
Why?
|
| Nurse's Role | 1 | 2009 | 14 | 0.080 |
Why?
|
| Risk | 1 | 2009 | 43 | 0.080 |
Why?
|
| Financing, Government | 2 | 2020 | 10 | 0.080 |
Why?
|
| Child Behavior | 1 | 2009 | 9 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 92 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 279 | 0.070 |
Why?
|
| Data Collection | 2 | 2024 | 38 | 0.070 |
Why?
|
| Pregnancy | 1 | 2010 | 599 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 112 | 0.070 |
Why?
|
| Professional-Family Relations | 2 | 2004 | 5 | 0.070 |
Why?
|
| Animals | 6 | 2017 | 1875 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 10 | 0.060 |
Why?
|
| Canada | 1 | 2006 | 3 | 0.060 |
Why?
|
| Japan | 1 | 2006 | 6 | 0.060 |
Why?
|
| Europe | 1 | 2006 | 15 | 0.060 |
Why?
|
| Australia | 1 | 2006 | 16 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 104 | 0.060 |
Why?
|
| Comorbidity | 1 | 2026 | 147 | 0.060 |
Why?
|
| Child Abuse | 2 | 2017 | 4 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 63 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2004 | 46 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2026 | 208 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2023 | 10 | 0.050 |
Why?
|
| Ecosystem | 1 | 2023 | 8 | 0.050 |
Why?
|
| Pleurisy | 1 | 2002 | 1 | 0.050 |
Why?
|
| Tetracycline | 1 | 2002 | 2 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 10 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 73 | 0.050 |
Why?
|
| Skilled Nursing Facilities | 1 | 2022 | 7 | 0.050 |
Why?
|
| Chromatin | 2 | 1998 | 3 | 0.040 |
Why?
|
| Calcineurin | 1 | 2001 | 1 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2001 | 3 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2001 | 9 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2001 | 8 | 0.040 |
Why?
|
| Motor Skills | 1 | 2001 | 2 | 0.040 |
Why?
|
| Fatigue | 1 | 2001 | 7 | 0.040 |
Why?
|
| Reaction Time | 1 | 2001 | 12 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2001 | 6 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2001 | 246 | 0.040 |
Why?
|
| Government Regulation | 1 | 2020 | 1 | 0.040 |
Why?
|
| Policy Making | 1 | 2020 | 5 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2001 | 36 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2020 | 11 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 89 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2001 | 65 | 0.040 |
Why?
|
| Base Sequence | 2 | 2017 | 65 | 0.040 |
Why?
|
| Problem Solving | 1 | 1999 | 4 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 1999 | 19 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1998 | 2 | 0.040 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 1998 | 2 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1998 | 5 | 0.040 |
Why?
|
| Actins | 1 | 1998 | 28 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2001 | 70 | 0.040 |
Why?
|
| Societies, Medical | 1 | 1999 | 67 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2017 | 13 | 0.030 |
Why?
|
| Mice | 3 | 2010 | 746 | 0.030 |
Why?
|
| Contraception | 1 | 2017 | 7 | 0.030 |
Why?
|
| Folic Acid | 1 | 2017 | 3 | 0.030 |
Why?
|
| Metagenome | 1 | 2017 | 4 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2017 | 18 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 5 | 0.030 |
Why?
|
| Alaska | 1 | 2017 | 1 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 7 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 18 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 20 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 1996 | 9 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2017 | 67 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 1996 | 11 | 0.030 |
Why?
|
| Social Welfare | 1 | 2016 | 2 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 98 | 0.030 |
Why?
|
| Social Determinants of Health | 1 | 2016 | 22 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2016 | 61 | 0.030 |
Why?
|
| Self Concept | 1 | 2015 | 10 | 0.030 |
Why?
|
| Students, Health Occupations | 1 | 2015 | 1 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2015 | 10 | 0.030 |
Why?
|
| Cardiology | 1 | 2015 | 15 | 0.030 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 2 | 2006 | 2 | 0.030 |
Why?
|
| Volunteers | 1 | 2013 | 2 | 0.030 |
Why?
|
| DNA Helicases | 3 | 1998 | 3 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 42 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 268 | 0.020 |
Why?
|
| Antisocial Personality Disorder | 1 | 2010 | 1 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2010 | 6 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2010 | 7 | 0.020 |
Why?
|
| New York City | 1 | 2010 | 14 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2010 | 6 | 0.020 |
Why?
|
| Headache | 1 | 2010 | 3 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 45 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 14 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2010 | 7 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2001 | 38 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2010 | 15 | 0.020 |
Why?
|
| Migraine Disorders | 1 | 2010 | 10 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2010 | 28 | 0.020 |
Why?
|
| Language | 1 | 2009 | 9 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2009 | 14 | 0.020 |
Why?
|
| Communication Barriers | 1 | 2009 | 4 | 0.020 |
Why?
|
| Cultural Characteristics | 1 | 2009 | 11 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 17 | 0.020 |
Why?
|
| Income | 1 | 2009 | 30 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 321 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 82 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 155 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 8 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1998 | 8 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 1998 | 38 | 0.020 |
Why?
|
| Treatment Refusal | 1 | 2007 | 3 | 0.020 |
Why?
|
| Education | 1 | 2007 | 11 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2006 | 1 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 1 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 2 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 3 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2006 | 5 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2006 | 6 | 0.020 |
Why?
|
| Antibodies | 1 | 2006 | 16 | 0.020 |
Why?
|
| Ligands | 1 | 2006 | 17 | 0.020 |
Why?
|
| Protein Binding | 1 | 2006 | 29 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2006 | 23 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 27 | 0.010 |
Why?
|
| Victoria | 1 | 2004 | 1 | 0.010 |
Why?
|
| Middle Ear Ventilation | 1 | 2004 | 2 | 0.010 |
Why?
|
| Hearing Tests | 1 | 2004 | 5 | 0.010 |
Why?
|
| Pleura | 1 | 2002 | 1 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 2002 | 1 | 0.010 |
Why?
|
| Fibrin | 1 | 2002 | 5 | 0.010 |
Why?
|
| Epithelium | 1 | 2002 | 22 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 2002 | 4 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 18 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 48 | 0.010 |
Why?
|
| Body Fluids | 1 | 2002 | 8 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 53 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 231 | 0.010 |
Why?
|
| Body Patterning | 1 | 2001 | 1 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2001 | 1 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2001 | 5 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2001 | 3 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 13 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2001 | 8 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 40 | 0.010 |
Why?
|
| Biomarkers | 1 | 2002 | 214 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2001 | 30 | 0.010 |
Why?
|
| Heart | 1 | 2001 | 25 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2001 | 31 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2001 | 150 | 0.010 |
Why?
|
| Calcium | 1 | 2001 | 117 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2001 | 101 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 1998 | 1 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1998 | 5 | 0.010 |
Why?
|
| Cattle | 1 | 1998 | 13 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 1998 | 6 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 25 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1998 | 1 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 6 | 0.010 |
Why?
|
| Binding Sites | 1 | 1998 | 24 | 0.010 |
Why?
|
| Cell Line | 1 | 1998 | 124 | 0.010 |
Why?
|
| KB Cells | 1 | 1996 | 1 | 0.010 |
Why?
|
| Reading Frames | 1 | 1996 | 1 | 0.010 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 1996 | 1 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 2 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 1996 | 2 | 0.010 |
Why?
|
| Oncogenes | 1 | 1996 | 4 | 0.010 |
Why?
|
| Multigene Family | 1 | 1996 | 6 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 25 | 0.010 |
Why?
|
| Muscles | 1 | 1996 | 19 | 0.010 |
Why?
|
| Trans-Activators | 1 | 1996 | 10 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 40 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1996 | 34 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1996 | 110 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1996 | 18 | 0.010 |
Why?
|
| Pancreas | 1 | 1996 | 144 | 0.010 |
Why?
|